Literature DB >> 28158635

Diagnosing an Infection Control Risk.

Preeta K Kutty1, L Clifford McDonald1.   

Abstract

Entities:  

Keywords:  Clostridium difficile; transmission; diagnosis; infection control

Mesh：

Year:  2017        PMID： 28158635      PMCID： PMC5729764          DOI： 10.1093/cid/cix085

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  9 in total

1.  Effect Of Detecting and Isolating Asymptomatic Clostridium difficile Carriers-Reply.

Authors:  Yves Longtin; Rodica Gilca; Vivian G Loo
Journal:  JAMA Intern Med       Date:  2016-10-01       Impact factor: 21.873

2.  Role of fecal Clostridium difficile load in discrepancies between toxin tests and PCR: is quantitation the next step in C. difficile testing?

Authors:  J L Leslie; S H Cohen; J V Solnick; C R Polage
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-20       Impact factor: 3.267

3.  Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission.

Authors:  Scott R Curry; Carlene A Muto; Jessica L Schlackman; A William Pasculle; Kathleen A Shutt; Jane W Marsh; Lee H Harrison
Journal:  Clin Infect Dis       Date:  2013-07-23       Impact factor: 9.079

4.  Utility of a commercial PCR assay and a clinical prediction rule for detection of toxigenic Clostridium difficile in asymptomatic carriers.

Authors:  Curtis J Donskey; Venkata C K Sunkesula; Annette L Jencson; Nimalie D Stone; Carolyn V Gould; L Clifford McDonald; Matthew Samore; Jeanmarie Mayer; Susan Pacheco; Susan Sambol; Laurica Petrella; Deborah Terry; Dale N Gerding
Journal:  J Clin Microbiol       Date:  2013-10-23       Impact factor: 5.948

5.  Burden of Clostridium difficile infection in the United States.

Authors:  Fernanda C Lessa; Yi Mu; Wendy M Bamberg; Zintars G Beldavs; Ghinwa K Dumyati; John R Dunn; Monica M Farley; Stacy M Holzbauer; James I Meek; Erin C Phipps; Lucy E Wilson; Lisa G Winston; Jessica A Cohen; Brandi M Limbago; Scott K Fridkin; Dale N Gerding; L Clifford McDonald
Journal:  N Engl J Med       Date:  2015-02-26       Impact factor: 91.245

6.  Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.

Authors:  Christopher R Polage; Clare E Gyorke; Michael A Kennedy; Jhansi L Leslie; David L Chin; Susan Wang; Hien H Nguyen; Bin Huang; Yi-Wei Tang; Lenora W Lee; Kyoungmi Kim; Sandra Taylor; Patrick S Romano; Edward A Panacek; Parker B Goodell; Jay V Solnick; Stuart H Cohen
Journal:  JAMA Intern Med       Date:  2015-11       Impact factor: 21.873

7.  Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection.

Authors:  Timothy D Planche; Kerrie A Davies; Pietro G Coen; John M Finney; Irene M Monahan; Kirsti A Morris; Lily O'Connor; Sarah J Oakley; Cassie F Pope; Mike W Wren; Nandini P Shetty; Derrick W Crook; Mark H Wilcox
Journal:  Lancet Infect Dis       Date:  2013-09-03       Impact factor: 25.071

8.  Contribution to Clostridium Difficile Transmission of Symptomatic Patients With Toxigenic Strains Who Are Fecal Toxin Negative.

Authors:  Damian P C Mawer; David W Eyre; David Griffiths; Warren N Fawley; Jessica S H Martin; T Phuong Quan; Timothy E A Peto; Derrick W Crook; A Sarah Walker; Mark H Wilcox
Journal:  Clin Infect Dis       Date:  2017-05-01       Impact factor: 9.079

9.  Diverse sources of C. difficile infection identified on whole-genome sequencing.

Authors:  Derrick W Crook; Mark H Wilcox; Tim E A Peto; A Sarah Walker; David W Eyre; Madeleine L Cule; Daniel J Wilson; David Griffiths; Alison Vaughan; Lily O'Connor; Camilla L C Ip; Tanya Golubchik; Elizabeth M Batty; John M Finney; David H Wyllie; Xavier Didelot; Paolo Piazza; Rory Bowden; Kate E Dingle; Rosalind M Harding
Journal:  N Engl J Med       Date:  2013-09-26       Impact factor: 91.245
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.